|
|
Today's journal articles
No journal articles today
Do you need further information on any of the agents being evaluated in the trial(s) below? Let us know...
New Clinical Trials
No clinical trials today
Previous Journal Entries
Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.
Synthesis and Biological Evaluation of Some Novel Thieno[2,3 - d]pyrimidine Derivatives as Potential Anti - inflammatory and Analgesic Agents.
Pharmacokinetics and Dose Proportionality of Fentanyl Sublingual Spray: a Single-Dose 5-Way Crossover Study.
Antihyperalgesic Effect of Buprenorphine Involves Nociceptin/Orphanin FQ Peptide-Receptor Activation in Rats With Spinal Nerve Injury-Induced Neuropathy.
The Effect of Gabapentin Premedication on Postoperative Nausea, Vomiting, and Pain in Patients on Preoperative Dexamethasone Undergoing Craniotomy for Intracranial Tumors.
A Phase II Trial of Human Secretin Infusion for Refractory Type B Pain in Chronic Pancreatitis.
Blockade of substance P receptor attenuates osteoporotic pain, but not bone loss, in ovariectomized mice.
Effects of parecoxib on morphine analgesia after gynecology tumor operation: a randomized trial of parecoxib used in postsurgical pain management.
The Safety of Liposome Bupivacaine, A Novel Local Analgesic Formulation.
Time to onset of analgesia following local infiltration of liposome bupivacaine in healthy volunteers: a randomized, single-blind, sequential cohort, crossover study.
Synergistic analgesic effects between neuronostatin and morphine at the supraspinal level.
Topical amitriptyline combined with ketamine for the treatment of erythromelalgia: a retrospective study of 36 patients at mayo clinic.
Impact of local administration of liposome bupivacaine for postsurgical analgesia on wound healing: a review of data from ten prospective, controlled clinical studies.
Biological Active Analogues of the Opioid Peptide Biphalin: Mixed α/β(3) - Peptides.
Activation of Cannabinoid Receptor 2 Inhibits Experimental Cystitis.
Design and synthesis of new bifunctional sigma - 1 selective ligands with antioxidant activity.
Targeting anti-inflammatory treatment can ameliorate injury-induced neuropathic pain.
ARA290 in a Rat Model of Inflammatory Pain.
Expression of CXCR3 on Specific T Cells Is Essential for Homing to the Prostate Gland in an Experimental Model of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Assessment of allodynia relief by tissue-protective molecules in a rat model of nerve injury-induced neuropathic pain.
|
Today's News Items
No news items selected today
Training Courses & Meetings
No events listed
Previous News Items
Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain
|
If this icon appears after any of our listed articles, the author is able to provide reprints. Articles denoted by an Licensing Op. icon describe data relevant to licensing opportunities. The report icon, 
, links through to full analyses relating to pharmaceutical/market developments relating to this work
